ATRenew, China’s largest platform for pre-owned electronics, is offering trade-in incentives to coincide with the Lunar New ...

Read about Brookfield Renewable Partners, Intel, Apple and more in the latest Market Talks covering Technology, Media and ...

Baird analyst Garrett Holland changed his rating on the stock to Hold from Buy and cut his price target to $130 from $160.

UBS tests Key4 Gold service on Ethereum's zkSync network, marking a significant step in traditional finance's adoption of blockchain technology.

Prices rose by just 0.1 per cent on the month or 4.1 per cent year on year, lender Nationwide said. That fell short of forecasts of a 0.3 per cent rise.

The company, which sells Hoka, Ugg, and Teva footwear, told investors late Thursday that the company doesn't see demand ...

According to UBS India strategist Anubhav Agarwal, the impact of the budget on the markets is expected to be muted, given ...

The Swiss banking giant, which has been experimenting with blockchain, tapped the layer-2 firm to test whether it could scale ...

UBS upgraded ResMed (RMD) to Buy from Neutral with a price target of $290, up from $255. The firm thinks consensus is too cautious in the ...

The break up plans of Smiths Group today sent the industrial conglomerate’s shares 15% or 277p higher to a record 2142p. The ...

FinTech Magazine rounds up this week's top stories, from Bitcoin's endorsement at Davos to Visa's African fintech partnership ...

UBS analyst Timothy Chiodo maintained a Buy rating on Visa (V – Research Report) today and set a price target of $400.00. The company’s shares ...